Skip to main content
Download PDF
- Main
Nondisclosure of HIV Status in a Clinical Trial Setting: Antiretroviral Drug Screening Can Help Distinguish Between Newly Diagnosed and Previously Diagnosed HIV Infection
- Marzinke, Mark A;
- Clarke, William;
- Wang, Lei;
- Cummings, Vanessa;
- Liu, Ting-Yuan;
- Piwowar-Manning, Estelle;
- Breaud, Autumn;
- Griffith, Sam;
- Buchbinder, Susan;
- Shoptaw, Steven;
- del Rio, Carlos;
- Magnus, Manya;
- Mannheimer, Sharon;
- Fields, Sheldon D;
- Mayer, Kenneth H;
- Wheeler, Darrell P;
- Koblin, Beryl A;
- Eshleman, Susan H;
- Fogel, Jessica M
- et al.
Published Web Location
https://doi.org/10.1093/cid/cit672Abstract
In The HIV Prevention Trials Network 061 study, 155 human immunodeficiency virus (HIV)-infected men reported no prior HIV diagnosis; 83 of those men had HIV RNA levels of <1000 copies/mL at enrollment. Antiretroviral drug testing revealed that 65 of the 83 (78.3%) men were on antiretroviral treatment. Antiretroviral drug testing can help distinguish between newly diagnosed and previously diagnosed HIV infection.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.